In heart failure with reduced ejection fraction, vericiguat was associated with a reduction in all-cause death. But are the data strong enough to make the drug a new addition to the standard of care?

A new class of antihypertensive agent that blocks the production of aldosterone has shown impressive results in patients with resistant or uncontrolled hypertension.

A meta-analysis shows newer anticoagulants are safer than warfarin, especially for serious bleeding complications like ...

Australian blood supplier Lifeblood drops sexual activity wait times for most plasma donations and adopts gender-neutral ...

In one of two trials with myosin inhibitors for hypertrophic cardiomyopathy, one showed effectiveness for the obstructive type, while the other fell flat against the non-obstructive form.

Patient-reported anxiety before surgery may predict the risk for postoperative delirium in the postanesthesia care unit, a ...

A home-based AF screening strategy was well accepted in a new study, but whether it will be worthwhile for widescale use is unclear.

A meta-analysis reports that nonpharmacologic interventions improve esophageal sphincter pressure and reduce acid exposure ...

As the connection between obesity, psoriasis, and PsA grows clearer, so does the potential of GLP-1 RAs. Explore their ...

National breastfeeding policies in Latin America remain outdated, despite strong evidence that antiretroviral therapy ...

Energy-reduced Mediterranean diet plus exercise significantly lowers the risk for T2D in adults with overweight or obesity ...

A new study shows that US medical schools accepted fewer students traditionally underrepresented in medicine after a 2023 ...